Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vedolizumab for the Treatment of Collagenous Gastritis

NCT06317220 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06317220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06317220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vedolizumab for the Treatment of Collagenous Gastritis
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 3, 2024
Completion date
October 31, 2026
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

collagenous gastritis